CDKN2A and chronic myelogenous leukemia, BCR-ABL1 positive: Also, at the transcriptional level, ARF expression is increased in patients with haematological malignancies, especially in the early stage of CML (chronic myelogenous leukemia), suggesting that this over-expression could be associated with CML development [121].